Early Diagnosis Research Alliance
A new approach to early diagnosis - bringing the brightest research minds together to make earlier diagnosis in pancreatic cancer a reality
Previous investments in early diagnosis research have been too small, infrequent and isolated, meaning that the best efforts of researchers have yet to succeed. To solve this problem, we’re taking a different approach.
The Pancreatic Cancer UK Early Diagnosis Research Alliance is one of the biggest investments in early diagnosis within pancreatic cancer in the UK. By sharing information and knowledge and coordinating efforts, some of the UK’s leading researchers are working together to develop and implement a simple test that doctors can use to diagnose people earlier and save lives.
This pioneering research is close to the biggest and most exciting breakthrough we’ve ever seen – the first effective test to detect pancreatic cancer in the blood. Preliminary results show that the test is currently getting greater than 95% accuracy in early trials, meaning we are one step closer to improving one of biggest challenges in pancreatic cancer research and ultimately, saving more lives.
Leading the large team of researchers that form the Alliance is Professor Steve Pereira, University College London, who has over 20 years of experience in working in pancreatic cancer. His previous research into early diagnosis and biomarker testing has served as vital groundwork for this project, increasing biomarker test sensitivity, and highlighting the challenges in delivering diagnosis in the UK healthcare system.
The four priority areas
In order to achieve their goal, the Alliance will look to accelerate early diagnosis for the most common forms of pancreatic cancer, pancreatic adenocarcinoma (PDAC) and pancreatic neuroendocrine tumours (PNET) by focussing on four key areas.
The Alliance has been made possible through the generous support of Nicki’s Smile and Dan Blake, together with funds generated by other supporters.
The funds raised by our supporters have made this possible. But this programme is only funded until 2021. We need additional investment to drive the next phase and make this test a reality by 2024.